Your Health Plan:
Your Health Plan:
Not SelectedEVRYSDI (risdiplam) is a brand-name prescription drug for treatment of Spinal Muscular Atrophy. EVRYSDI is a survival of motor neuron 2 splicing modifier. It is available in the form of oral solution.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $14700-17400.
Patient Assistance Prorgams and Coupons are found:
No other option is found for EVRYSDI